© 2021 BioMarin. All rights reserved.

BioMarin to Participate in the Virtual BofA Securities 2021 Napa Biopharma Conference
Jun 15, 2021

SAN RAFAEL, Calif., June 15, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in the BofA Securities 2021 Napa Biopharma Conference on June 16, 2021 at 3:30pm ET. An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.




Traci McCarty                                                   

Debra Charlesworth

BioMarin Pharmaceutical Inc.                            

BioMarin Pharmaceutical Inc.

(415) 455-7558                                                   

(415) 455-7451


SOURCE BioMarin Pharmaceutical Inc.